Brief summary of the agreement
Anyone is free:
· to copy, distribute, and display the work;
· to make derivative works;
· to make commercial use of the work;
Under the following conditions: Attribution
· the original author must be given credit;
· for any reuse or distribution, it must be made clear to others what the license terms of this work are;
· any of these conditions can be waived if the authors gives permission.
Statutory fair use and other rights are in no way affected by the above
Author Biographies
Manasse Nzayirambaho
National University of Rwanda School of Public Health, Kigali, Rwanda
Jean De Dieu Bizimana
National University of Rwanda School of Public Health, Kigali, Rwanda
Robert Jean Freund
École des Hautes Etudes en Santé Publique, Rennes, France
Pascal Millet
Centre René-Labusquière, Université Victor-Segalen Bordeaux-2, Bordeaux, France
François-Xavier Merrien
Faculté des Sciences Sociales et Politiques, Université de Lausanne, Lausanne, Switzerland
Gilles Potel
Laboratoire EA 3826 (Thérapeutiques Cliniques et Expérimentales des Infections), UFR Médecine et Techniques Médicales, Université de Nantes, Nantes, France
Pierre Lombrail
Laboratoire de Santé Publique et d’Epidémiologie, UFR Médecine et Techniques Médicales, Université de Nantes, Nantes, France
Main Article Content
Impact of Home-Based Management of malaria combined with other community-based interventions: what do we learn from Rwanda?
Manasse Nzayirambaho
Jean De Dieu Bizimana
Robert Jean Freund
Pascal Millet
François-Xavier Merrien
Gilles Potel
Pierre Lombrail
Abstract
Introduction: This study aimed to evaluate the impact of home-based management of malaria (HBM) strategy on time to treatment and reported presumed malaria morbidity in children aged less than 5 years in Rwanda. Methods: The study was carried out in two malaria-endemic rural districts, one where HBM was applied and the other serving as control. In each district, a sample of mothers was surveyed by questionnaire before (2004) and after (2007) implementation of HBM. Results: After implementation, we observed: i) an increase (P<0.001) in the number of febrile children treated within 24 hours of symptom onset in the experimental district (53.7% in 2007 vs 5% in 2004) compared with the control district (28% vs 7.7%); ii) a decrease in the reported number of febrile children in the experimental district (28.7% vs 44.9%, P<0.01) compared with the control district (45.7% vs 56.5%, P<0.05). Conclusion: HBM contributed to decrease time to treatment and reported presumed malaria morbidity.
Pan African Medical Journal 2013; 14:50
Donate
AJOL is a Non Profit Organisation that cannot function without donations.
AJOL and the millions of African and international researchers who rely on our free services are deeply grateful for your contribution.
AJOL is annually audited and was also independently assessed in 2019 by E&Y.
Your donation is guaranteed to directly contribute to Africans sharing their research output with a global readership.
Once off donations here:
For annual AJOL Supporter contributions, please view our Supporters page.
Tell us what you think and showcase the impact of your research!
Please take 5 minutes to contribute to our survey so that we can better understand the contribution that African research makes to global and African development challenges. Share your feedback to help us make sure that AJOL's services support and amplify the voices of researchers like you.